Ascendis Pharma A/s · NASDAQ:ASND
Bienaime Jean Jacques bought 2,000 Ascendis Pharma A/s shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 18, 2026
On Aug 14, 2026, Bienaime Jean Jacques (Director) bought 2,000 Ascendis Pharma A/s shares at an average US$246.33 for US$493K, leaving 2,900 shares. Filed Aug 18, 2026 (Form 4).
- Bought
- 2,000 shares
- Price
- US$246.33 average (US$245.85 to US$246.91)
- Value
- US$493K
- Holding after
- 2,900 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Ordinary Shares | Buy | 1,100 | US$245.85 | 2,000 | Direct |
| Aug 14, 2026 | Ordinary Shares | Buy | 900 | US$246.91 | 2,900 | Direct |
Source
Related
- Ascendis Pharma A/s
- Bienaime Jean Jacques
- Ascendis Pharma A/s shareholders
- Form 4 · Bienaime Jean Jacques · Jun 1, 2026
- Form 4 · Bienaime Jean Jacques · May 27, 2026
- Form 4 · Bodenhoff Mads · Sep 9, 2026
- Form 4 · Holtug Lars · Sep 3, 2026
- Form 4 · Smith Scott Thomas · Jun 2, 2026
- Form 4 · Smith Scott Thomas · Jun 1, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026